(Q83798044)

English

Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments

scientific article published on 06 April 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

editorial

0 references

title

Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

2

Darren K McGuire

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1

M Odette Gore

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

publication date

6 April 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

published in

European Heart Journal

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

volume

32

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

issue

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

page(s)

1832-1834

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

Identifiers

DOI

10.1093/EURHEARTJ/EHR019

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

PubMed publication ID

21471136

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471136

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471136%20AND%20SRC:MED&resulttype=core&format=json

(Q83798044)

Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)